Target intelligence / Profile preview

Ribosomal protein L5 pseudogene 24 (RPL5P24)

Target
RPL5P24
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L5 pseudogene 24 (RPL5P24) is a non-functional, processed pseudogene corresponding to the ribosomal protein L5 gene. Pseudogenes like RPL5P24 are segments of DNA that resemble functional genes but have accumulated mutations (such as frameshifts or premature stop codons) that prevent them from being expressed as functional proteins[2][8]. RPL5P24 is cataloged in gene and genome resources (for example, NCBI Gene: 100270841) and is one of several pseudogenes related to RPL5, but it does not contribute to known cellular functions, has no established role in pathophysiology, and is not a therapeutic or molecular target[2][8]. RPL5 (not the pseudogene) is a component of the large ribosomal subunit (60S) and participates in protein synthesis as well as extra-ribosomal roles in cell cycle regulation and tumor suppression[1][4][7]. Pseudogenes like RPL5P24 arise via duplication or retrotransposition events, resulting in gene-like sequences that remain in the genome but are generally transcriptionally inactive and non-functional[8]. Such pseudogenes are not considered functional targets for therapeutics, receptors, enzymes, or biomarkers, and their presence is primarily of bioinformatic interest or for evolutionary studies[8].

Other names
RPL5P24RPL5_9_935
02

Mechanism of action

None

03

Biological functions

None (does not encode a functional product)
04

Disease associations

None directly; no reported role in disease as a pseudogene

Beyond the preview

Go deeper on Ribosomal protein L5 pseudogene 24 (RPL5P24).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L5 pseudogene 24 (RPL5P24).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call